港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

雍和植髮（臨時代碼）

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：- -

香港流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

市銷率: - -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

交銀國際：重申康方生物(09926)「買入」評級目標價63港元

康方生物－Ｂ(09926-HK)跌6.09%

康方生物-B：雙抗龍頭再創佳績，biopharma進階之路正式開啓

格隆匯港股通5日資金流入流出排行榜 | 4月9日

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/90010"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"90010","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","market":"HK","secType":"STK","nameCN":"雍和植髮（臨時代碼）","latestPrice":0,"timestamp":1771833600000,"preClose":0,"halted":8,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"02-23 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"symbolChange":{"newSymbol":"09926","executeDate":"2020-04-14"},"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1771810200000,1771819200000],[1771822800000,1771833600000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"90010\",,,,,undefined,":{"symbol":"90010","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/90010\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2020-04-14","symbol":"90010","oldSymbol":"90010","newSymbol":"09926","exchange":"SEHK","type":"symbolChange","dateTimestamp":1586793600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"90010\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"90010\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"90010\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2127509492","title":"交銀國際：重申康方生物(09926)「買入」評級 目標價63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2127509492","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2127509492?lang=zh_tw&edition=fundamental","pubTime":"2021-04-13 11:01","pubTimestamp":1618282909,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研究报告，重申康方生物“买入”评级，目标价63港元。报告中称，公司去年收入为1.24亿元人民币，主要为政府补贴和利息收入。净亏损13.2  亿元人民币，主要因为高于预期的研发支出，以及可转换可赎回优先股的公允价值损失。管理层预计，2021年下半年将就宫颈癌适应症提交新药注册。另外，旗下治疗三线经典霍奇金淋巴瘤适应症的AK105已提交新药注册，预计今年上市。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/447500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03329","09926","90010"],"gpt_icon":0},{"id":"2126530057","title":"康方生物－Ｂ(09926-HK)跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2126530057","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126530057?lang=zh_tw&edition=fundamental","pubTime":"2021-04-12 15:13","pubTimestamp":1618211580,"startTime":"0","endTime":"0","summary":"康方生物-B(09926-HK)截至15:09下跌6.09%，现报50.1港元，跌3.25港元。成交198万股，涉资1.01亿元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202104121880562382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["90010","09926"],"gpt_icon":0},{"id":"2126239062","title":"康方生物-B：雙抗龍頭再創佳績，biopharma進階之路正式開啓","url":"https://stock-news.laohu8.com/highlight/detail?id=2126239062","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126239062?lang=zh_tw&edition=fundamental","pubTime":"2021-04-12 09:30","pubTimestamp":1618191054,"startTime":"0","endTime":"0","summary":"PD-1单药Balstilimab的ORR为11.9%，Pembrolizumab的ORR为14.3%。02 AK112：联合抗血管机制，First-in-Class品种AK112则是全球目前唯一进入临床开发阶段的基于PD-1/VEGF的双抗产品，也是康方继AK104之后第二款全球首创并进入临床开发阶段的双抗药物。未来，康方生物的AK112上市之后，或将成为另一个极具竞争力的重磅双抗产品。康方生物与中国生物制药旗下正大天晴共同开发及商业化派安普利单抗，派安普利是中国生物制药唯一可用于开发基于PD-1抗体的单一疗法或联合疗法的新药。","market":"us","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7700101bk55.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://k.sina.cn/article_5115326071_130e5ae7700101bk55.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["09926","90010"],"gpt_icon":0},{"id":"2126086036","title":"格隆匯港股通5日資金流入流出排行榜 | 4月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2126086036","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2126086036?lang=zh_tw&edition=fundamental","pubTime":"2021-04-10 05:10","pubTimestamp":1618002602,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，心动公司，微盟集团，山东墨龙，康方生物-B，海吉亚医疗港股通五日资金显著流入，五日持仓占比变动分别为，1.04%，0.51%，0.44%，0.29%，0.27%。港股通数据为T+2数据，即今日披露数据为前两个交易日数据。","market":"us","thumbnail":"https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1fc1f5e2fa377c378fa230c10e0849a2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/data-rss/detail?id=2332","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_gelonghui","symbols":["90010","09926"],"gpt_icon":0}],"pageSize":4,"totalPage":28,"pageCount":1,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/90010\",params:#limit:6,delay:false,,,undefined,":[]}}